Senti Biosciences, Inc. (SNTI) Dividend History

Senti Biosciences, Inc. is a biotechnology company focused on developing programmable cell therapies using synthetic biology. The company's platform integrates genetic engineering and computational design to create advanced cell-based medicines aimed at treating diseases such as cancer, autoimmune disorders, and rare genetic conditions.

2 Corporate Drive, First Floor, South San Francisco, CA, 94080
Phone: (650) 382-3281
Website: https://www.sentibio.com

Dividend History

Senti Biosciences, Inc. currently does not pay dividends

Company News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amerant Bancorp Inc. - AMTB

Amerant Bancorp Inc. (AMTB) reported Q1 2025 earnings that missed consensus estimates, causing its stock price to drop 13.09%. Pomerantz LLP is investigating potential securities fraud or other unlawful business practices by the company and its officers/directors.

GlobeNewswire Inc.

Featured Companies: AMTB LSTR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Senti Biosciences, Inc. - SNTI

Senti Biosciences, Inc. (SNTI) has stopped enrollment in a clinical trial for its solid tumor pipeline product SN301A due to observed dose-limiting toxicities, causing a 27.2% drop in the company's stock price.

GlobeNewswire Inc.
Senti Bio to Present at the Citizens JMP Life Sciences Conference

Senti Biosciences, a clinical-stage biotechnology company, announced that it will present positive preliminary clinical results of its lead program SENTI-202 in the treatment of patients with Relapsed/Refractory AML on May 8, 2025.

GlobeNewswire Inc.
NK Cell Therapy Market on Track for Exponential Growth Amid Rising Pipeline Developments | DelveInsight

The NK cell therapy market is experiencing significant growth, driven by rising interest in immuno-oncology and advancements in cell engineering technologies. Key players are investing in innovative approaches, including combination therapies and gene-modified NK cells, to improve clinical outcomes.

GlobeNewswire Inc.

Featured Companies: ARTV FATE
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Autonomix Medical (NASDAQ:AMIX), Absci ... - Benzinga

Several healthcare stocks saw significant price movements in Thursday's pre-market session, with notable gainers including Autonomix Medical, Inspire Veterinary, and Salarius Pharmaceuticals, while Gain Therapeutics, Senti Biosciences, and Aspira Womens Health declined.

Benzinga

Featured Companies: AMIX GANX IVP SLRX

Dividend data last updated 06/07/2025 15:37:47 UTC